Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel.
Sign Up to like & getrecommendations! Published in 2022 at "Emerging infectious diseases"
DOI: 10.3201/eid2805.220141
Abstract: We estimated vaccine effectiveness (VE) of the BNT162b2 (Pfizer-BioNTech, https://www.pfizer.com) booster dose against SARS-CoV-2 infection and reduction of complications (hospitalization, severe disease, and death) among breakthrough cases in persons in Israel >16 years of age… read more here.
Keywords: cov infection; sars cov; breakthrough complications; booster ... See more keywords